Edition:
United Kingdom

Otonomy Inc (OTIC.OQ)

OTIC.OQ on NASDAQ Stock Exchange Global Select Market

3.72USD
20 Jul 2018
Change (% chg)

$0.03 (+0.68%)
Prev Close
$3.70
Open
$3.65
Day's High
$3.75
Day's Low
$3.65
Volume
3,572
Avg. Vol
62,525
52-wk High
$21.15
52-wk Low
$2.80

Chart for

About

Otonomy, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of therapeutics for diseases and disorders of the ear. The Company's product candidates include OTIPRIO, OTO-104 and OTO-311. OTIPRIO is a single-dose, physician-administered antibacterial, which is used for the treatment... (more)

Overall

Beta: --
Market Cap(Mil.): $104.55
Shares Outstanding(Mil.): 30.30
Dividend: --
Yield (%): --

Financials

  OTIC.OQ Industry Sector
P/E (TTM): -- 85.33 32.76
EPS (TTM): -3.46 -- --
ROI: -53.30 2.22 14.61
ROE: -53.63 3.86 16.34

BRIEF-Otonomy Qtrly Loss Per Share $0.37

* OTONOMY REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

09 May 2018

BRIEF-Otonomy Qtrly Loss Per Share $‍0.62​

* OTONOMY REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

08 Mar 2018

BRIEF-Otonomy Announces FDA Approval Of Otiprio For Acute Otitis Externa

* OTONOMY ANNOUNCES FDA APPROVAL OF OTIPRIO(R) FOR ACUTE OTITIS EXTERNA

02 Mar 2018

Competitors

  Price Chg
Novartis AG (NOVN.S) CHF82.20 +1.24

Earnings vs. Estimates